• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Neonode

Neonode

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Neon Therapeutics Enters License Agreement with the Netherlands Cancer Institute for Neoantigen-based T Cell Therapeutics

    Neon Therapeutics Enters License Agreement with the Netherlands Cancer Institute for Neoantigen-based T Cell Therapeutics

  2. Trolls' Animates Dreams of a Franchise -- WSJ

    Trolls' Animates Dreams of a Franchise -- WSJ

12

©2017 Morningstar Advisor. All right reserved.